Funded Grants

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Varmus, Harold E.

Weill Medical Coll Of Cornell Univ
United States

Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells 5U01CA224326-05 Eva Szabo, M.D.
Bast, Robert C

University Of Tx Md Anderson Can Ctr
United States

MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm 2U01CA200462-06A1
Furuta, Saori

Case Western Reserve University
United States

Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer 5R01CA248304-05
Punnen, Sanoj

University Of Miami School Of Medicine
United States

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 1R01CA272766-01A1 Matthew Young, Ph.D.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05
Olopade, Olufunmilayo F.

University Of Chicago
United States

Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA) 1R01CA276652-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Borges, Chad R

Arizona State University-Tempe Campus
United States

Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions 5R21CA269091-02 RFA-CA-21-005 (R21 Clinical Trial Not Allowed)
Ghosh, Jayashri

Temple Univ Of The Commonwealth
United States

Development of blood-based methylation biomarkers for CRC risk prediction 1R01CA281948-01 Matthew Young, Ph.D.